Lineage Cell Therapeutics (LCTX) Cost of Revenue (2011 - 2025)
Lineage Cell Therapeutics' (LCTX) quarterly Cost of Revenue came in at $66000.0 in Q4 2025, down 57.14% year-on-year from $154000.0 in Q4 2024, and up 1220.0% quarter-over-quarter from $5000.0 in Q3 2025.
Lineage Cell Therapeutics (LCTX) Cost of Revenue (2011 - 2025) Analysis & Trends
Lineage Cell Therapeutics' Cost of Revenue history runs 15 years deep, the most recent figure standing at $66000.0 for Q4 2025.
- On a quarterly basis, Cost of Revenue fell 57.14% year-over-year to $66000.0 in Q4 2025; TTM through Mar 2026 was $110000.0, a 59.56% decrease from a year earlier, with the FY2025 full-year figure at $146000.0, down 56.29% from the prior year.
- Cost of Revenue rose to $66000.0 in Q4 2025 per LCTX's latest filing, from $5000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $985000.0 in Q3 2021 and bottomed at $5000.0 in Q3 2025.
- The 5-year median for Cost of Revenue is $122000.0 (2021), against an average of $165250.0.
- Across the five-year window, Cost of Revenue jumped 865.69% in 2021 and plunged 86.84% in 2025, its largest moves.
- Year by year, Cost of Revenue stood at $204000.0 in 2021, then sank by 50.0% to $102000.0 in 2022, then surged by 150.98% to $256000.0 in 2023, then sank by 39.84% to $154000.0 in 2024, then plunged by 57.14% to $66000.0 in 2025.
- Per Business Quant, the three latest LCTX Cost of Revenue figures stand at $66000.0 (Q4 2025), $5000.0 (Q3 2025), and $39000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 254.83 Mn | 192.11 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66,000.00 |
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Sep 30, 2023 | 169,000.00 |